| Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study RK Burt, Y Loh, B Cohen, D Stefosky, R Balabanov, G Katsamakis, ... The Lancet Neurology 8 (3), 244-253, 2009 | 393 | 2009 |
| Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial IN van Schaik, V Bril, N van Geloven, HP Hartung, RA Lewis, G Sobue, ... The Lancet Neurology 17 (1), 35-46, 2018 | 263 | 2018 |
| Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up RK Burt, RM Craig, F Milanetti, K Quigley, P Gozdziak, J Bucha, A Testori, ... Blood, The Journal of the American Society of Hematology 116 (26), 6123-6132, 2010 | 207 | 2010 |
| Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia RK Burt, A Testori, Y Oyama, HE Rodriguez, K Yaung, M Villa, JM Bucha, ... Bone marrow transplantation 45 (1), 111-116, 2010 | 123 | 2010 |
| Replicative senescence, aging and growth-regulatory transcription factors GP Dimri, A Testori, M Acosta, J Campisi Neurosignals 5 (3), 154-162, 2004 | 106 | 2004 |
| The helix‐loop‐helix protein Id‐1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts E Hara, JA Uzman, GP Dimri, JO Nehlin, A Testori, J Campisi Developmental genetics 18 (2), 161-172, 1996 | 99 | 1996 |
| Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis Y Oyama, WG Barr, L Statkute, T Corbridge, EA Gonda, B Jovanovic, ... Bone marrow transplantation 40 (6), 549-555, 2007 | 93 | 2007 |
| Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned? RK Burt, A Testor, R Craig, B Cohen, R Suffit, W Barr Journal of autoimmunity 30 (3), 116-120, 2008 | 88 | 2008 |
| Coming of age in culture J Campisi, GP Dimri, JO Nehlin, A Testori, K Yoshimoto Experimental gerontology 31 (1-2), 7-12, 1996 | 61 | 1996 |
| A pilot study of high‐dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation IR Melamed, M Heffron, A Testori, K Lipe Autism Research 11 (3), 421-433, 2018 | 44 | 2018 |
| Direct cloning of unmodified PCR products by exploiting an engineered restriction site A Testori, I Listowsky, P Sollitti Gene 143 (1), 151-152, 1994 | 29 | 1994 |
| Autologous hematopoietic stem cell transplantation for systemic sclerosis F Milanetti, J Bucha, A Testori, R K Burt Current stem cell research & therapy 6 (1), 16-28, 2011 | 25 | 2011 |
| Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies ISJ Merkies, IN van Schaik, JM Léger, V Bril, N van Geloven, HP Hartung, ... Journal of the peripheral nervous system 24 (1), 48-55, 2019 | 22 | 2019 |
| Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review RA Lewis, DR Cornblath, HP Hartung, G Sobue, JP Lawo, O Mielke, ... Journal of the peripheral nervous system 25 (3), 230-237, 2020 | 18 | 2020 |
| Subcutaneous immunoglobulins: product characteristics and their role in primary immunodeficiency disease I Melamed, A Testori, Z Spirer International reviews of immunology 31 (6), 451-461, 2012 | 18 | 2012 |
| DNA-binding proteins in protein kinase C preparations A Testori, CST Hii, A Fournier, LA Burgoyne, AW Murray Biochemical and biophysical research communications 156 (1), 222-227, 1988 | 18 | 1988 |
| Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: results from the pre‐randomization phase of the … O Mielke, V Bril, DR Cornblath, JP Lawo, N van Geloven, HP Hartung, ... Journal of the peripheral nervous system 24 (1), 72-79, 2019 | 15 | 2019 |
| Senescence responsive transcriptional element J Campisi, A Testori US Patent 5,965,543, 1999 | 14 | 1999 |
| Cloning Unmodified PCR Products Using Engineered Xcml Restriction Sites in a Portable Cassette A Testori, P Sollitti PCR Cloning Protocols: From Molecular Cloning to Genetic Engineering, 89-100, 1997 | 9 | 1997 |
| Neurologic manifestations of hereditary angioedema A Testori, I Melamed Annals of Allergy, Asthma & Immunology 118 (1), 119-120, 2017 | 6 | 2017 |
